RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
A Phase 1b/2a Trial of Tofacitinib, an Oral Janus Kinase Inhibitor, in Systemic Lupus Erythematosus
2019-01-01 Hasni, S; Gupta, S; Davis, M; Poncio, E; Temesgen-Oyelakin, Y; Carlucci, P; Wang, Xh; Naqi, M; Playford, M; Goel, R; Li, Xb; Biehl, A; Ochoa-Navas, I; Manna, Z; Shi, Yh; Thomas, D; Chen, Jg; Biancotto, A; Apps, R; Cheung, F; Kotliarov, Y; Babyak, A; Stagliano, K; Tsang, J; Tsai, W; Vian, L; Gazaniga, N; Giudice, V; Brooks, S; Mackay, M; Gregersen, P; Diamond, B; Mehta, N; Remaley, A; O'Shea, J; Gadina, M; Kaplan, M
A simple flow cytometric score based on CD49d and homing marker expression in chronic lymphocytic leukemia (CLL).
2017-01-01 Giudice, V; Rinaldi, A; Ferrara, I; Martorelli, Mc; Pezzullo, L; Fontana, R; Langella, M; Guariglia, R; Serio, B; Rocco, M; Villani, G; Selleri, C.
Accelerated and persistent bone loss after autologous and allogeneic stem cell transplantation
2013-01-01 Serio, B; Pezzullo, L; Fontana, R; Annunziata, S; Rosamilio, R; Ferrara, I; Rocco, M; Giudice, V; De Rosa, G; Ricci, P; Montuori, N; Selleri, Carmine
Anaplastic CD30+ alk- (micro) lymphoma arising out of mediastinal Plasma Cell Castleman’s disease in immunocompetent patient treated by rituximab- dexametasone and continuous lenalidomide
2013-01-01 Fontana, R; Baldi, C; Sabattini, E; Napolitano, C; Pezzullo, L; Giudice, V; Valvano, L; Selleri, Carmine
Autologous And Allogeneic Stem Cell Transplantation Is Associated With Long-Lasting Endocrine Disorders
2014-01-01 Sessa, M; Giudice, V; Serio, B; Pezzullo, L; Selleri, Carmine
BONE MARROW MESENCHYMAL STEM CELLS AS FACILITATOR OF RUXOLITINIB-MEDIATED INHIBITION OF JAK2 MUTADED CELLS
2019-01-01 Marino, L; Charlier, B; Giudice, V; Dal Piaz, F; Pingeon, M; Vitolo, R; Rosamilio, R; Izzo, B; Villani, G; Montuori, N; Serio, B; Izzo, V; Filippelli, A; Selleri, C
Combined liposomal amphotericin b and surgery as successful management for pulmunary mucormycosis in a patient with acute myeloid leukemia
2013-01-01 Serio, B; Pezzullo, L; Fontana, R; Annunziata, S; Giudice, V; Sessa, M; Ferrara, I; De Luca, C; Rocco, M; Selleri, Carmine
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation
2013-01-01 Pezzullo, L; Fontana, R; Serio, B; Annunziata, S; Sessa, M; Rosamilio, R; Ferrara, I; Giudice, V; Villani, G; Rocco, M; Selleri, Carmine
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation increases the number of circulating natural killer cells
2014-01-01 Pezzullo, L.; Fontana, R.; Serio, B.; Annunziata, S.; Sessa, M.; Ferrara, I.; Giudice, V.; Esposito, B.; Villani, G.; Rocco, M.; Selleri, Carmine
CRISPR/Cas9-Induced DNM3TA Mutations in the K562 Human Leukemic Cell Line as a Model of DNMT3A-Mutated Leukemogenesis
2016-01-01 Banaszak, Lg; Giudice, V; Zhao, X; Wu, Z; Hosokawa, K; Keyvan, K; Townsley, Dm; Kajigaya, S; Young, Ns.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A Phase 1b/2a Trial of Tofacitinib, an Oral Janus Kinase Inhibitor, in Systemic Lupus Erythematosus | 1-gen-2019 | Hasni, S; Gupta, S; Davis, M; Poncio, E; Temesgen-Oyelakin, Y; Carlucci, P; Wang, Xh; Naqi, M; Playford, M; Goel, R; Li, Xb; Biehl, A; Ochoa-Navas, I; Manna, Z; Shi, Yh; Thomas, D; Chen, Jg; Biancotto, A; Apps, R; Cheung, F; Kotliarov, Y; Babyak, A; Stagliano, K; Tsang, J; Tsai, W; Vian, L; Gazaniga, N; Giudice, V; Brooks, S; Mackay, M; Gregersen, P; Diamond, B; Mehta, N; Remaley, A; O'Shea, J; Gadina, M; Kaplan, M | |
| A simple flow cytometric score based on CD49d and homing marker expression in chronic lymphocytic leukemia (CLL). | 1-gen-2017 | Giudice, V; Rinaldi, A; Ferrara, I; Martorelli, Mc; Pezzullo, L; Fontana, R; Langella, M; Guariglia, R; Serio, B; Rocco, M; Villani, G; Selleri, C. | |
| Accelerated and persistent bone loss after autologous and allogeneic stem cell transplantation | 1-gen-2013 | Serio, B; Pezzullo, L; Fontana, R; Annunziata, S; Rosamilio, R; Ferrara, I; Rocco, M; Giudice, V; De Rosa, G; Ricci, P; Montuori, N; Selleri, Carmine | |
| Anaplastic CD30+ alk- (micro) lymphoma arising out of mediastinal Plasma Cell Castleman’s disease in immunocompetent patient treated by rituximab- dexametasone and continuous lenalidomide | 1-gen-2013 | Fontana, R; Baldi, C; Sabattini, E; Napolitano, C; Pezzullo, L; Giudice, V; Valvano, L; Selleri, Carmine | |
| Autologous And Allogeneic Stem Cell Transplantation Is Associated With Long-Lasting Endocrine Disorders | 1-gen-2014 | Sessa, M; Giudice, V; Serio, B; Pezzullo, L; Selleri, Carmine | |
| BONE MARROW MESENCHYMAL STEM CELLS AS FACILITATOR OF RUXOLITINIB-MEDIATED INHIBITION OF JAK2 MUTADED CELLS | 1-gen-2019 | Marino, L; Charlier, B; Giudice, V; Dal Piaz, F; Pingeon, M; Vitolo, R; Rosamilio, R; Izzo, B; Villani, G; Montuori, N; Serio, B; Izzo, V; Filippelli, A; Selleri, C | |
| Combined liposomal amphotericin b and surgery as successful management for pulmunary mucormycosis in a patient with acute myeloid leukemia | 1-gen-2013 | Serio, B; Pezzullo, L; Fontana, R; Annunziata, S; Giudice, V; Sessa, M; Ferrara, I; De Luca, C; Rocco, M; Selleri, Carmine | |
| Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation | 1-gen-2013 | Pezzullo, L; Fontana, R; Serio, B; Annunziata, S; Sessa, M; Rosamilio, R; Ferrara, I; Giudice, V; Villani, G; Rocco, M; Selleri, Carmine | |
| Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation increases the number of circulating natural killer cells | 1-gen-2014 | Pezzullo, L.; Fontana, R.; Serio, B.; Annunziata, S.; Sessa, M.; Ferrara, I.; Giudice, V.; Esposito, B.; Villani, G.; Rocco, M.; Selleri, Carmine | |
| CRISPR/Cas9-Induced DNM3TA Mutations in the K562 Human Leukemic Cell Line as a Model of DNMT3A-Mutated Leukemogenesis | 1-gen-2016 | Banaszak, Lg; Giudice, V; Zhao, X; Wu, Z; Hosokawa, K; Keyvan, K; Townsley, Dm; Kajigaya, S; Young, Ns. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 40
- 1 Contributo su Rivista::1.5 Abst... 40
Data di pubblicazione
- 2023 1
- 2022 4
- 2021 5
- 2019 2
- 2018 3
- 2017 1
- 2016 6
- 2014 8
- 2013 10
Rivista
- HAEMATOLOGICA 14
- BLOOD 13
- BONE MARROW TRANSPLANTATION 8
- TRANSLATIONAL MEDICINE @ UNISA 3
- ARTHRITIS & RHEUMATOLOGY 1
- DRUG SAFETY 1
Keyword
- autologous bone graft 2
- HEMATOPOIETIC STEM CELL MOBILIZATION 1
Lingua
- eng 40
Accesso al fulltext
- no fulltext 40